E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/7/2019 in the Prospect News Bank Loan Daily.

Surgical Specialties wraps $235 million term B at Libor plus 500 bps

By Sara Rosenberg

New York, May 7 – Surgical Specialties Corp. completed syndication of its $235 million six-year term loan B at pricing of Libor plus 500 basis points, the high end of the Libor plus 475 bps to 500 bps talk, according to a market source.

As before, the term loan has a 0% Libor floor and an original issue discount of 99.

The company’s $265 million of credit facilities also include a $30 million five-year revolver.

Capital One and SunTrust Robinson Humphrey Inc. are the joint bookrunners on the deal.

Proceeds will be used to refinance existing debt.

Surgical Specialties is a medical device company that markets surgical products.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.